Our Pipeline

희귀질환치료제
Program Indication Gene Technology Discovery IND-Enabling Phase 1 Phase 2 Phase 3
NP3011 산필리포증후군 A형
(MPSIIIA)
SGSH ERT
(ICV)
NP3021 GM1 강글리오시드증
(GM1 Gangliosidosis)
GLB1 ERT
(ICV)
NP3022 모르퀴오 증후군 B형
(MPSIVB)
GLB1 ERT
(IV)
NP3031 크라베병
(Krabbe Disease)
GALC ERT
(ICV)
- 척수성 근위축증
(SMA)
SMN1 -
- 글루타르산뇨증 1형
(Glutaric aciduria type 1)
GCDH -
NP1031

프래더-윌리 증후군
(Prader-Willi Syndrome)

- Oxytocin
장기지속형 호르몬 치료제
Program Indication Technology Discovery IND-Enabling Phase 1 Phase 2 Phase 3
NP1116

전립선암
(Prostate Cancer)

성조숙증
(Central Precocious Puberty)

GnRH Agonist
    IND Approved
NP1021 성장호르몬 결핍증
(Growth Hormone Deficiency)
Growth Hormone